30 closest matches · ranked by relevance
Infant Respiratory Distress Syndrome · Respiratory Insufficiency · Apnea of Prematurity
Primary: pCO2 Measurements Post-intervention, as Compared to Pre-intervention Values — 50; 45 mm Hg — p=0.011
High-Frequency Ventilation · Intermittent Positive-Pressure Ventilation · Newborn Morbidity
Primary: Partial Pressure CO2 (pCO2) : Data From the Crossover Phase of the Study — 38.7; 36.8 mm Hg
Intubated Infants Were Intend to Extubation Using Noninvasive Ventilation Strategies
Primary: Duration of Invasive Mechanical Ventilation — 6.3; 7.8; 7.3 day
Episodic Hypoxemia in Mechanically Ventilated Preterm Infants
Primary: Percentage of Time Spent With Arterial Oxygen Saturation < 75% — 5; 4.4 % of time — p=0.44
Preterm Infants
Primary: Number of Participants Who Required Intubation — 26; 15 Participants
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Daytime Partial Pressure of Carbon Dioxide in Arterial Blood (PaCO2) — 53; 50 mmHg — p=0.01
Hypercapnic Respiratory Failure · Chronic Obstructive Pulmonary Disease · Dyspnea
Primary: Rated Perceived Dyspnea [RPD] — 5.4; 5.6; 3.97; 4.54 units on a scale (0-10)
Bronchial Asthma · Asthma · Status Asthmaticus
Primary: The Primary Endpoint Will be Time to Readiness for Discharge. — 1.74; 1.75 days
High Flow Nasal Cannula
Primary: Percent Change in Pressure-rate Product (PRP) as a Function of Increasing HFNC Flow Rate on Both Types of HFNC Delivery System (FP and VT) — -10; -20; -23 percent change…
Ventilators, Mechanical · Work of Breathing
Primary: Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider — 76 percentage adherant
Acute Respiratory Failure
Primary: Treatment Failure Rate — 13; 7; 87; 97 Participants
Ventilator Induced Lung Injury · Cardiac Disease · Acute Lung Injury
Primary: Severity of Pulmonary Complications in the Post-operative Period — 15; 26 percentage of participants — p=0.016
Healthy Adult Volunteers
Primary: Change in End-expiratory Lung Volume — -144; 103 mL
Bronchopulmonary Dysplasia
Primary: Number of Days Being Intubated — 12.4; 6.2 days
Atelectasis
Primary: Improvement of Atelectasis — 6; 7; 3; 6 participants
Cystic Fibrosis · Bronchiectasis
Primary: TV — 0.93; 1.00; 1.07 L
Respiratory Failure · Mechanical Ventilation · Acute Lung Injury
Primary: To Further Characterize ED Mechanical Ventilation — 500 mL
Dyspnea · Lactic Acidosis · Muscle
Primary: Blood Lactate Change — 1.19; 1.22; 1.11; 1.05 mmol/L
to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates
Primary: Treatment Failure Within 72 Hours After Randomization 72 Hours After Randomization Need for Invasive Mechanical Ventilation — 48; 27 Participants
Oxygen Deficiency · Desaturation of Blood · Hypoventilation
Primary: Number of Surgical Interruptions — 0.645; 0.302 Interruptions — p=0.206
Cystic Fibrosis
Primary: Lung Function: Lung Clearance Index — 9; 9.7 lung clearance index
Upper Airway Surgery
Primary: Surgical Case Completion Rate Using HVNI With or Without Converting to Alternative Mode of Oxygenation — 19; 7; 5 Participants
Respiratory Failure
Primary: Duration of Mechanical Ventilation — 129.5; 208.1 hours
Healthy
Primary: Change in End-expiratory Lung Impedance From Baseline Measured by Electrical Impedance Tomography (EIT) — 9; 74; 132; 7 Change in EELI (arbitrary units)
Airway Secretion Clearance
Primary: Hospital Length of Stay — 2.95; 5.45 days
Apnea of Prematurity
Primary: Number of Participants Who Were Intubated — 6; 8 Participants
Apnea During Procedural Sedation
Primary: Percentage of Time the Patient Will Experience Apnea — 11 % time in apnea of total study duration
COPD · Chronic Bronchitis · Emphysema
Primary: The Primary Outcome Measure is the Rate of Exacerbations as Defined Using the Winnipeg Criteria. — 5.5; 4 exacerbations per 12 weeks
Respiratory Failure
Primary: Ventilator-free Days (VFDs) to Day 28 After Enrollment — 23; 22; 24 Ventilator-free days to day 28
Respiratory Insufficiency · Infant, Newborn, Disease
Primary: Respiratory Severity Score (MAP X FiO2) — 3.83; 3.82; 3.46; 3.86 score on a scale